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Effect of maternal nutrition on fetal adipocyte development1
T. D. Jennings2, K. R. Underwood3, A. E. Wertz‐Lutz4, and A. D. Weaver3
Department of Animal and Range Sciences, South Dakota State University
BEEF 2010‐11
SUMMARY
The objective of this experiment was to determine the effects of maternal nutrition on the expression of
genes in fetal tissues. Genes of interest were selected because each has been demonstrated previously
to influence body composition. Twenty‐two Angus‐cross bred heifers (BW = 1161 ± 19 lbs) randomly
were assigned to three dietary treatments. Maternal dietary treatments were formulated and intake
was controlled to provide 150% (HIGH), 100% (INT), and 80% (LOW) of maintenance energy
requirements for growing pregnant Angus heifers (NRC, 2000). Heifers were on dietary treatment from d
85 to d 180 of gestation, at which point fetuses were removed via cesarean section and muscle,
subcutaneous fat, and liver samples were collected. At trial initiation dam BW was similar between
treatment groups. Dam BW differed (P = 0.002) at the end of the treatment period as a result of dietary
treatment. Final BW was lowest for the LOW dams, intermediate for INT dams, and highest for HIGH
dams. Both ribfat thickness and ribeye area were increased in the HIGH treatment group compared with
LOW and INT dams (P < 0.05). Thus, dam growth was influenced by diet during treatment period.
Dietary treatment did not influence fetal weight, crown rump length, liver weight, or right hind leg
weight of the fetus. Relative gene expression for preadipocyte factor‐1 was more highly expressed (P <
0.05) in HIGH heifers as compared with INT and LOW heifers. These preliminary results suggest that fetal
growth characteristics are not affected by manipulation of maternal nutrition during mid‐gestation in
beef cows. However, gene expression differences could potentially lead to differences in composition of
growth, and warrants further investigation.
INTRODUCTION
Value added beef programs such as Certified Angus Beef, Sterling Silver, and Certified Hereford Beef
bring increased revenue to livestock producers. However, the antagonistic relationship of input cost and
livestock prices often offset potential profit. Identifying methods to gain premiums paid by value‐added
programs would help ease the financial burden of beef production. Rapid growth of the bio‐fuel
industry over recent years has contributed to increased cost of finishing cattle. The small improvement
in marbling score achieved by extending days on feed will not offset the current price of prolonged
feeding. Therefore, alternative means that allow cattle to reach their genetic potential must be
identified. Instead of placing emphasis the finishing phase to improve quality grades, one possible
method would be to alter the nutrition status of the dam.
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Most research regarding the influence of nutrition on marbling focuses on postnatal growth. However,
several studies with sheep, humans, and rats have reported adipose tissue in the fetus can be
manipulated by maternal nutrition (Clarke et al., 1998; Bispham et al., 2003; Singhal et al., 2003; Ford et
al., 2007). Recent research in sheep indicates that maternal nutrition during gestation influences
intramuscular adipocyte development of the fetuses (Tong et al., 2008). Therefore, it may be possible to
influence intramuscular adipocyte development in cattle through manipulation of maternal nutrition
during gestation. A preadipocyte is an undifferentiated adipocyte. Preadipocyte factor‐1 (pref‐1) is
present in preadipocyte cell membranes and is highly expressed in undifferentiated preadipocytes that
are not yet capable of depositing fat. Yet, the expression of pref‐1 is absent in mature adipocytes. Sul et
al., (2000) proposed that pref‐1 appears to be produced by preadipocytes and prevents differentiation
to mature adipocytes. Therefore, increased expression of pref‐1 could be used to identify preadipocytes
in fetal tissues.
Consumers have shown a willingness to pay for higher quality, more flavorful, and juicier beef (Platter et
al., 2005). Unfortunately, the majority of new post‐natal adipose tissue is primarily relegated to
subcutaneous fat, seam fat, and visceral fat, which all have negative effects on yield grade (Faust et al.,
1978; Miller et al., 1984; Valet et al., 2002). Proper nutrient management during fetal development may
allow for increases in intramuscular fat without decreasing cutability. Studying the response of nutrient
restriction and over‐feeding during mid to late gestation could identify feeding methods to improve
marbling. It was hypothesized that fetuses from overfed beef cows will have increased intramuscular
adipose development. The objective of this experiment was to observe the effect that a positive and
negative maternal nutrient status have on gene expression responsible for differentiation of fetal
adipocytes.
MATERIALS AND METHODS
Forty‐five Angus crossbred heifers of similar genetic background were artificially inseminated using
sexed (female selected) semen from a single Angus bull to remove potential effects of genetics and sex.
All procedures were approved by the SDSU Animal Care and Use Committee, and cesarean sections
were performed by the university veterinarian. Heifers were synchronized and inseminated within the
same week. Before artificial insemination, subcutaneous fat thickness was measured between the 12th
and 13th ribs at the three‐quarter position of the Longissimus muscle (LM) using an Aloka 500V real‐time
ultrasound machine (Aloka, Wallingford, CT) to establish initial fat thickness (FT). Body condition score
(BCS) for each heifer was determined. Heifers received a common diet until breeding, and throughout
early gestation (d 85). Management of heifers was conducted at a remote site pretreatment.
Pregnancy status was evaluated at d 44 of gestation, and 23 heifers were determined to be pregnant.
Heifers were transported to the South Dakota State University (SDSU), and bred heifers (n = 23) were
assigned randomly to a dietary treatment on d 85 of gestation.
During treatment heifers were housed at the SDSU feedlot. Dietary treatment groups were: low (n = 8;
LOW; 1152 ± 32 lb of initial BW), intermediate (n = 7; INT; 1180 ± 34 lb of initial BW), and high (n = 8;
HIGH; 1150 ± 32 lb of initial BW). All dietary treatments were formulated in accordance to the beef
cattle NRC (2000). Heifers were offered feed twice daily; diets are reported in Table 1. The LOW, INT,
and HIGH diets were formulated and offered at an amount to achieve 80%, 100%, and 150%
maintenance energy requirements for a growing pregnant Angus heifer. Heifers were allowed ad libitum
access to water. Treatment diets were initiated on d 85 of gestation and continued through d 180 of
gestation when cesarean sections were performed. Body weight was recorded at the beginning and end
of treatment period and used to determine dam growth during treatment. Intermediate weights to
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monitor growth performance were reported at 14‐d intervals. Ultrasound measurements for FT and
ribeye area (REA) were recorded 12 d prior to treatment initiation and at d 170 of gestation to
determine dam body condition changes during treatment. Intermediate ultrasound measurements were
recorded at 28‐d intervals throughout treatment to monitor dam body condition. Blood samples were
collected from each treatment group before the beginning of dietary treatment (d 80), and again at d
130 and 177 of gestation.
Table 1. Dry matter and nutrient contents of diets
Treatments
Ingredientsa
Grass hay
Wheat straw
Dry rolled corn
Soy hulls

LOW
62.50
32.50

‐
‐

Low supplement b
High supplement

5.00

b

Calculated nutrient composition
Crude protein, %
Ca, %
P, %
NEg, Mcal/ lb
NEm, Mcal/ lb
TDN, %

INT
95.00

HIGH
60.00

‐
‐
‐
‐

‐
15.00
20.00

‐

‐

5.00

5.00

7.75
0.37
0.23
0.23
0.48

10.66
0.39

11.44
0.37
0.25
0.38
0.66
65.3

0.25
0.26
0.53

52.7

55.5

a

% Dry matter basis.
b
Provided vitamins and minerals to meet nutrient requirements (Beef NRC, 2000).

Table 2. % Dry matter intake and composition
Item
LOW
DMI, lb/d
19.55
NEm intake, Mcal/d
9.42
a
% NEm req
78.68
CP intake, lb/d
1.54
b
MP intake, lb/d
1.14
% MP reqc
90.13

INT
20.62
10.95
91.57
2.40
1.82
143.30

HIGH
27.00
17.92
149.62
3.11
2.32
182.60

a

NEm intake expressed as a percentage of requirement predicted by Beef NRC, 2000.
Predicted based on degradability of protein sources included in the diet.
c
MP requirement predicted using the equation 3.8 x BW(kg)0.75 MP intake then was expressed as a percentage of
MP requirement.
b

Twenty‐three heifers were used at trial initiation; however one heifer aborted at approximately d 164 of
gestation. Therefore, twenty‐two (n = 22) heifers received a standing left side cesarean section, on d
179, 180, or 181 of gestation. Anesthesia was performed by a field block infusion of the proposed
incision site in a line block pattern using 60‐80 mL of 2% lidocaine to desensitize the incision site. This
was combined with either a low caudal epidural 10‐20 mg xylazine combined with 3‐5 ml of 2%
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lidocaine, or an intravenous sedation/analgesia with xylazine (0.05‐0.075mg/100 lb BW)/Liquamycin
Torbugesic (0.8‐1ml). Banamine (2 mL/100 lb BW) was given IV in the jugular vein and LA‐200 was given
IV (4.5 mL/100 lb BW) in the jugular vein for post surgical management. Heifers were observed twice
daily for two weeks following surgery for infection, loss of appetite, and to insure passing of placenta.
Fetal blood samples from the umbilical vein and heart were collected into K3‐EDTA vacutainer tubes, and
stored on ice until processing. Fetal BW and crown‐rump length were recorded and following blood
sample collection each fetus was exsanguinated by the umbilical vein. Samples from the LM were
collected from the left and right sides of the fetus by peeling back the hide and removing a 1‐inch
section of tissue on each side of the 13th rib; muscle and any visible subcutaneous fat located over the
LM were quickly diced, and snap frozen in liquid nitrogen. Brisket fat, udder fat and liver samples also
were removed, and snap frozen in liquid nitrogen. All fetal tissue samples were processed and frozen
within 25 minutes of removal from the dam.
Real‐Time PCR
TRI Reagent ® RT – RNA, DNA, protein isolation reagent (Molecular Research Center, Inc. Cincinnati, OH)
was used to extract mRNA from fetal LM samples. Muscle samples were powdered using a mortar,
pestle, and liquid nitrogen. Approximately 100 mg of powdered muscle was placed into 1 mL of TRI
Reagent RT. DNase I, Amplification Grade kit (Invitrogen, Roche Molecular Systems, Inc., Foster City,
California) was used to remove genomic DNA contamination, and to dilute the RNA concentration (200
ng/µL). A high‐capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA) converted RNA
to cDNA. A Bio‐Rad MyCycler Thermocycler (Bio‐Rad Laboratories, Hercules, CA) was reverse transcribed
according to manufacturer’s instructions. Real‐time quantitative PCR analysis using reverse transcribed
cDNA was performed with a SYBR Green RT‐PCR kit from Bio‐Rad. Primer sets are indicated in Table 3.
Fold change was calculated by REST 2008 (Relative Expression Software Tool V2.0.07, Corbett Research
Pty, Ltd., Sydney, Australia). REST 2008 incorporates RT‐PCR reaction efficiencies, reference gene
normalization, and cycle thresholds values to determine statistical differences between treatment
samples and controls.
Table 3. Primer sequence for genes of interest
Genea

Primer sequence

Pref‐1

forward
reverse
forward
reverse

PPIA
a

5' ‐ TGTTGCGCAAGAAGAAGAACCTGC ‐ 3'
5' ‐ AAGAACAGACCGCACAGAGAGACA ‐ 3'
5' ‐ CATGCCCTCTTTCACCTTGCCAAA ‐ 3'
5' ‐ AGCATACAGGTCCTGGCATCTTGT ‐ 3'

Annealing
temperature
60°C
60°C
60°C
60°C

Pref‐1 = preadipocyte factor 1, PPIA = peptidylprolyl isomerase A.

Blood Samples and Analysis
Blood samples from the heart and umbilical cord were centrifuged at 1,100 x g at 4° C for 30 minutes.
Plasma was separated into 1‐mL aliquots and frozen for subsequent analysis of leptin, ghrelin, insulin,
growth hormone, and non‐esterified fatty acid concentration. To prevent protein degradation, the 1‐mL
aliquot designated for ghrelin was acidified with 50 μL of 1 N HCl and treated with 10 µL of a 10mg/mL
solution of phenylmethylsulfonyl fluoride (Sigma, St. Louis, MO).
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Dam performance and fetal growth characteristics were analyzed using the GLM procedure of SAS (SAS
Inst. Inc., Cary, NC) with dietary treatment group as the main effect. Dry matter intake was calculated
using pen as the experimental unit. Least square means were used to separate differences in treatment
means that resulted from dietary treatment. Real‐time PCR gene expression data were analyzed using
REST 2008 (Corbett Research Pty, Ltd., Sydney, Australia) to calculate fold change difference between
LOW, HIGH, and INT which served as the control.
RESULTS
Dam Growth Performance
Initial BW was similar between treatment groups. Total BW gain, ADG for dams during the treatment
period and final dam BW was greatest (P < 0.05) in the HIGH heifers, intermediate for INT heifers, and
lowest for LOW heifers (Table 4). Heifers in the LOW treatment groups were lighter in weight than INT
and HIGH heifers (P < 0.05). Average daily gains (Table 4) for LOW, INT, and HIGH were 0.97, 1.47, and
1.90 lb/d, respectively and differed (P < 0.05) as a result of treatment.
Table 4. Dam measures of performance during mid‐gestation (85 to 180 d) treatment period
Item
LOWa
INTa
HIGHa
SEM
P value
Initial BW, lb
1152.3
1180.7
1150.4
31.64
0.761
1244.1 c

Final BW, lb
ADG, lb/d

0.97

c

c

Total gain, lb
Initial FT, ine

92.3
0.18

Final FT, ine

0.21 c

Initial REA, in
Final REA, in

1319.6 bc

2f

2f

12.4
13.5

bc

1.47

bc

139.3
0.17

0.22 c
12.3

c

13.9

1348.7 b
1.90
b

180.9
0.18

0.32 b
12.7

c

b

15.4

b

35.65

0.120

0.17

0.004

16.16
0.02

0.004
0.814

0.02

< 0.001

0.65

0.863

0.64

0.099

a

Dietary treatment offered to dams from 85 to 180 d of gestation; LOW 79% NEm requirement; INT 92% NEm
requirement; HIGH 150% NEm requirement.
b, c, d
Means within rows that do not have common superscripts differ, P < 0.05.
e
Ultrasound‐measured fat thickness (FT); Initial measure 12 d prior to initiation of dietary treatments and final
measured following 84 d of dietary treatment.
f
Ultrasound‐measured ribeye area; Initial measure 12 d prior to initiation of dietary treatments and final
measured following 84 d of dietary treatment.

Dam Body Composition
The treatment diets contributed to differences in body condition. Subcutaneous fat changed over time.
Ultrasound fat thickness of HIGH heifers was greater than INT and LOW heifers (P < 0.05); but similar for
INT and LOW dams (Table 4). In addition, HIGH heifers had greater final REA than INT and LOW heifers (P
< 0.05), which were similar.
Fetal Data
Treatment did not influence fetal weight (Table 5) which indicates that the dam was able to provide the
necessary nutrients to the fetus. There were no differences in crown rump length, liver weight, or right
hind leg weight as a result of maternal nutrition during mid‐gestation.
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Table 5. Measures of fetal performance
Variable a
BW, lb
LW, lb
CRL, in
RLW, lb

LOWb
14.6
0.41
20.7
1.5

INTb
15.4
0.44
21.3
1.5

HIGHb
14.8
0.43
20.8
1.5

SEM
0.44
0.014
0.21
0.06

P value
0.454
0.558
0.159
0.726

a

BW = fetal body weight, LW = fetal liver weight, CRL = crown rump length, RLW = right hind leg weight.
Dietary treatment offered to dams from 85 to 180 d of gestation; LOW 79% NEm requirement; INT 92% NEm
requirement; HIGH 150% NEm requirement.

b

Real‐time RT PCR analysis on fetal LM samples revealed differences in pref‐1 gene expression with
manipulation of maternal nutrition. The LOW and HIGH treatments were compared to INT, which served
as the control and its fold change set equals to 1.0. The HIGH diets resulted in increased expression (P <
0.05) of pref‐1 when compared with fetuses from INT and LOW dams (Figure 1). Expression of pref‐1

Pref‐1 Expression
1.6

a

1.4
1.2
Fold Change

b
1.0
0.8

b

0.6
0.4
0.2
0.0

LOW

INT

HIGH

Treatment groups
Figure 1. Relative gene expression for preadipocyte factor‐1 on fetal longissimus dorsi. Diets were formulated and intake
controlled to meet energy requirements at 79 (LOW), 92 (INT), and 150 (HIGH) percent of maintenance requirements (NRC,
2000). Bars represent mean treatment fold change. Fold changes for LOW and HIGH are compared to INT which serves as the
ab
control group and equals 1.0. Bars bearing different letters differ (P < 0.05).

was similar between LOW and INT fetuses. Higher expression of pref‐1 in LM of HIGH fetuses suggests
that either greater preadipocytes are present in the HIGH fetuses and are not yet present in LOW and
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INT fetuses, or it may suggest that differentiation of preadipocytes to mature adipocyte in intramuscular
adipose tissue is slowed in HIGH because pref‐1 inhibits preadipocyte differentiation.
IMPLICATIONS
These preliminary data suggest that manipulating the maternal nutrition of beef cows in mid‐gestation
does not affect the growth characteristics of the fetus. However, differences in gene expression warrant
further investigation as this could potentially lead to differences in composition of growth particularly
intramuscular fat deposition.
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